References
Boettner B, Van Aelst L . The RASputin effect. Genes Dev 2002; 16: 2033–2038.
Kolch W . Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interaction. Biochem J 2000; 351: 289–305.
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949–954.
Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE . RAF/RAS oncogenes and mismatch-repair status. Nature 2002; 418: 934.
Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM et al. High frequency of BRAF mutations in nevi. Nat Genet 2003; 33: 19–20.
Corradini P, Ladetto M, Voena C, Palumbo A, Inghirami G, Knowles DM et al. Mutational activation of N- and K-ras oncogene in plasma cell dyscrasias. Blood 1993; 81: 2708–2713.
Bezieau S, Avet-Loiseau H, Moisan JP, Bataille R . Activating Ras mutations in patients with plasma-cell disorders: a reappraisal. Blood 2002; 100: 1101–1104.
Smith ML, Snaddon J, Neat M, Cambal-Parrales M, Arch R, Lister TA et al. Mutation of BRAF is uncommon in AML FAB type M1 and M2. Leukemia 2003; 17: 274–275.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonello, L., Voena, C., Ladetto, M. et al. BRAF gene is not mutated in plasma cell leukemia and multiple myeloma. Leukemia 17, 2238–2240 (2003). https://doi.org/10.1038/sj.leu.2403116
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403116
- Springer Nature Limited
This article is cited by
-
Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary disease
Blood Cancer Journal (2013)
-
MEK inhibitors as a chemotherapeutic intervention in multiple myeloma
Blood Cancer Journal (2013)
-
BRAF mutations are very rare in B- and T-cell pediatric acute lymphoblastic leukemias
Leukemia (2008)
-
Mutations in the BRAF and N-ras genes in childhood acute lymphoblastic leukaemia
Leukemia (2005)
-
BRAF gene is not mutated in mismatch repair-proficient or -deficient plasma cell dyscrasias
Leukemia (2004)